Literature DB >> 30586505

Worldwide Frequencies of APOL1 Renal Risk Variants.

Girish N Nadkarni1, Christopher R Gignoux2, Elena P Sorokin3, Michelle Daya2, Rayees Rahman1, Kathleen C Barnes2, Christina L Wassel4, Eimear E Kenny5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30586505      PMCID： PMC6482949          DOI： 10.1056/NEJMc1800748

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  APOL1 risk variants, race, and progression of chronic kidney disease.

Authors:  Afshin Parsa; W H Linda Kao; Dawei Xie; Brad C Astor; Man Li; Chi-yuan Hsu; Harold I Feldman; Rulan S Parekh; John W Kusek; Tom H Greene; Jeffrey C Fink; Amanda H Anderson; Michael J Choi; Jackson T Wright; James P Lash; Barry I Freedman; Akinlolu Ojo; Cheryl A Winkler; Dominic S Raj; Jeffrey B Kopp; Jiang He; Nancy G Jensvold; Kaixiang Tao; Michael S Lipkowitz; Lawrence J Appel
Journal:  N Engl J Med       Date:  2013-11-09       Impact factor: 91.245

Review 2.  Therapeutics for APOL1 nephropathies: putting out the fire in the podocyte.

Authors:  Jurgen Heymann; Cheryl A Winkler; Maarten Hoek; Katalin Susztak; Jeffrey B Kopp
Journal:  Nephrol Dial Transplant       Date:  2017-01-01       Impact factor: 5.992

Review 3.  APOL1 nephropathy: from gene to mechanisms of kidney injury.

Authors:  Etty Kruzel-Davila; Walter G Wasser; Sharon Aviram; Karl Skorecki
Journal:  Nephrol Dial Transplant       Date:  2015-01-05       Impact factor: 5.992

4.  Apolipoprotein L1 Variants and Blood Pressure Traits in African Americans.

Authors:  Girish N Nadkarni; Geneviève Galarneau; Stephen B Ellis; Rajiv Nadukuru; Jinglan Zhang; Stuart A Scott; Claudia Schurmann; Rongling Li; Laura J Rasmussen-Torvik; Abel N Kho; M Geoffrey Hayes; Jennifer A Pacheco; Teri A Manolio; Rex L Chisholm; Dan M Roden; Joshua C Denny; Eimear E Kenny; Erwin P Bottinger
Journal:  J Am Coll Cardiol       Date:  2017-03-28       Impact factor: 24.094

5.  African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans.

Authors:  Doron M Behar; Saharon Rosset; Shay Tzur; Sara Selig; Guennady Yudkovsky; Sivan Bercovici; Jeffrey B Kopp; Cheryl A Winkler; George W Nelson; Walter G Wasser; Karl Skorecki
Journal:  Hum Mol Genet       Date:  2010-02-09       Impact factor: 6.150

6.  Determining the effects and challenges of incorporating genetic testing into primary care management of hypertensive patients with African ancestry.

Authors:  C R Horowitz; N S Abul-Husn; S Ellis; M A Ramos; R Negron; M Suprun; R E Zinberg; T Sabin; D Hauser; N Calman; E Bagiella; E P Bottinger
Journal:  Contemp Clin Trials       Date:  2015-12-30       Impact factor: 2.226

7.  Increased burden of cardiovascular disease in carriers of APOL1 genetic variants.

Authors:  Kaoru Ito; Alexander G Bick; Jason Flannick; David J Friedman; Giulio Genovese; Michael G Parfenov; Steven R Depalma; Namrata Gupta; Stacey B Gabriel; Herman A Taylor; Ervin R Fox; Christopher Newton-Cheh; Sekar Kathiresan; Joel N Hirschhorn; David M Altshuler; Martin R Pollak; James G Wilson; J G Seidman; Christine Seidman
Journal:  Circ Res       Date:  2013-12-30       Impact factor: 17.367
  7 in total
  30 in total

Review 1.  The Future of Genomic Studies Must Be Globally Representative: Perspectives from PAGE.

Authors:  Stephanie A Bien; Genevieve L Wojcik; Chani J Hodonsky; Christopher R Gignoux; Iona Cheng; Tara C Matise; Ulrike Peters; Eimear E Kenny; Kari E North
Journal:  Annu Rev Genomics Hum Genet       Date:  2019-04-12       Impact factor: 8.929

2.  Apolipoprotein L1 Testing in African Americans: Involving the Community in Policy Discussions.

Authors:  Bessie A Young; Erika Blacksher; Kerri L Cavanaugh; Barry I Freedman; Stephanie M Fullerton; Jeffrey B Kopp; Ebele M Umeukeje; Kathleen M West; James G Wilson; Wylie Burke
Journal:  Am J Nephrol       Date:  2019-09-03       Impact factor: 3.754

Review 3.  Ten years in: APOL1 reaches beyond the kidney.

Authors:  Joshua S Waitzman; Jennie Lin
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-07       Impact factor: 2.894

Review 4.  APOL1 Genetic Testing in Living Kidney Transplant Donors.

Authors:  Sumit Mohan; Ana S Iltis; Deirdre Sawinski; James M DuBois
Journal:  Am J Kidney Dis       Date:  2019-04-11       Impact factor: 8.860

5.  A common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients from a multi-ethnic biobank.

Authors:  Ryan W Walker; Gillian M Belbin; Elena P Sorokin; Tielman Van Vleck; Genevieve L Wojcik; Arden Moscati; Christopher R Gignoux; Judy Cho; Noura S Abul-Husn; Girish Nadkarni; Eimear E Kenny; Ruth J F Loos
Journal:  J Hepatol       Date:  2020-03-05       Impact factor: 25.083

6.  Cases in Precision Medicine: APOL1 and Genetic Testing in the Evaluation of Chronic Kidney Disease and Potential Transplant.

Authors:  Y Dana Neugut; Sumit Mohan; Ali G Gharavi; Krzysztof Kiryluk
Journal:  Ann Intern Med       Date:  2019-10-08       Impact factor: 25.391

7.  Effect of a Single Apolipoprotein L1 Gene Nephropathy Variant on the Risk of Advanced Lupus Nephritis in Brazilians.

Authors:  Gisele Vajgel; Suelen Cristina Lima; Diego Jeronimo S Santana; Camila B L Oliveira; Denise Maria N Costa; Pamela J Hicks; Maria Alina G M Cavalcante; Carl D Langefeld; Lucila Maria Valente; Sergio Crovella; Gianna Mastroianni Kirsztajn; Barry I Freedman; Paula Sandrin-Garcia
Journal:  J Rheumatol       Date:  2019-11-15       Impact factor: 4.666

Review 8.  APOL1 Nephropathy: From Genetics to Clinical Applications.

Authors:  David J Friedman; Martin R Pollak
Journal:  Clin J Am Soc Nephrol       Date:  2020-07-02       Impact factor: 8.237

Review 9.  Air, Land, and Sea: Gene-Environment Interaction in Chronic Disease.

Authors:  Russell A Wilke; Eric A Larson
Journal:  Am J Med       Date:  2021-07-31       Impact factor: 4.965

Review 10.  Kidney disease and APOL1.

Authors:  Aminu Abba Yusuf; Melanie A Govender; Jean-Tristan Brandenburg; Cheryl A Winkler
Journal:  Hum Mol Genet       Date:  2021-04-26       Impact factor: 6.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.